Your browser is no longer supported. Please, upgrade your browser.
TMCI [NASD]
Treace Medical Concepts, Inc.
Index- P/E- EPS (ttm)-0.25 Insider Own13.70% Shs Outstand52.77M Perf Week-9.53%
Market Cap1.04B Forward P/E- EPS next Y-0.25 Insider Trans-11.34% Shs Float34.22M Perf Month15.62%
Income-11.70M PEG- EPS next Q-0.01 Inst Own25.50% Short Float2.44% Perf Quarter-7.22%
Sales85.10M P/S12.23 EPS this Y12.20% Inst Trans0.41% Short Ratio2.38 Perf Half Y-31.62%
Book/sh1.85 P/B10.01 EPS next Y20.00% ROA- Target Price34.00 Perf Year-
Cash/sh1.95 P/C9.50 EPS next 5Y- ROE- 52W Range15.00 - 37.17 Perf YTD-0.70%
Dividend- P/FCF- EPS past 5Y- ROI3.60% 52W High-50.20% Beta-
Dividend %- Quick Ratio11.70 Sales past 5Y- Gross Margin80.50% 52W Low23.40% ATR1.45
Employees133 Current Ratio12.60 Sales Q/Q51.00% Oper. Margin-8.50% RSI (14)47.99 Volatility6.89% 7.99%
OptionableYes Debt/Eq0.30 EPS Q/Q-118.00% Profit Margin-13.80% Rel Volume0.68 Prev Close19.57
ShortableYes LT Debt/Eq0.30 EarningsNov 04 AMC Payout- Avg Volume350.97K Price18.51
Recom1.70 SMA20-1.34% SMA50-0.05% SMA200-28.04% Volume239,485 Change-5.42%
Jan-07-22Upgrade Morgan Stanley Equal-Weight → Overweight $30
May-18-21Initiated SVB Leerink Outperform $38
May-18-21Initiated Stifel Buy $35
May-18-21Initiated Morgan Stanley Equal-Weight $30
May-18-21Initiated JP Morgan Overweight $37
Jan-19-22 04:15PM  
09:22AM  
Jan-10-22 07:00AM  
Jan-07-22 08:00AM  
Dec-28-21 09:15AM  
Dec-23-21 09:15AM  
Nov-30-21 04:15PM  
Nov-18-21 10:31AM  
Nov-15-21 11:39AM  
Nov-09-21 04:05PM  
Nov-05-21 10:01AM  
Nov-04-21 04:05PM  
Oct-21-21 04:15PM  
Oct-14-21 04:15PM  
Oct-04-21 08:00AM  
Oct-01-21 08:00AM  
Sep-23-21 04:15PM  
Sep-13-21 04:57PM  
Sep-02-21 04:05PM  
Sep-01-21 10:00AM  
Aug-08-21 02:30AM  
Aug-05-21 04:05PM  
Jul-27-21 04:05PM  
Jul-23-21 07:45AM  
May-25-21 04:05PM  
02:15PM  
May-19-21 01:30PM  
May-18-21 08:00AM  
May-12-21 08:00AM  
Apr-23-21 12:07PM  
Apr-22-21 09:55PM  
09:00PM  
Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of device and/or biologic solutions for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical improvement. The company also provides Lapiplasty Mini-Incision precision system. In addition, it offers products to address ancillary surgical procedures, including akin osteotomies, weil osteotomies, intercuneiform stabilization, lesser tarsometatarsal joint fusions, and autograft bone harvesting, as well as for MTP fusion. Treace Medical Concepts, Inc. was incorporated in 2014 and is headquartered in Ponte Vedra Beach, Florida.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
TREACE JAMES TDirectorJan 19Sale18.9932,063608,9631,386,441Jan 20 06:08 PM
TREACE JAMES TDirectorJan 18Sale19.4642,937835,5681,418,504Jan 20 06:08 PM
Scanlan Sean F.SVP, MarketingJan 11Option Exercise1.198,83810,5408,838Jan 12 08:01 PM
Scanlan Sean F.SVP, MarketingJan 11Sale20.128,838177,8460Jan 12 08:01 PM
Scanlan Sean F.SVP, MarketingJan 10Option Exercise1.5738,86261,01338,862Jan 12 08:01 PM
Scanlan Sean F.SVP, MarketingJan 10Sale20.1638,862783,5320Jan 12 08:01 PM
Scanlan Sean F.SVP, MarketingJan 05Option Exercise1.578001,256800Jan 05 08:57 PM
Scanlan Sean F.SVP, MarketingJan 05Sale20.0280016,0180Jan 05 08:57 PM
Scanlan Sean F.SVP, MarketingJan 04Option Exercise1.57500785500Jan 05 08:57 PM
Scanlan Sean F.SVP, MarketingJan 04Sale20.0050010,0000Jan 05 08:57 PM
Scanlan Sean F.SVP, MarketingJan 03Option Exercise1.571,0001,5701,000Jan 05 08:57 PM
Scanlan Sean F.SVP, MarketingJan 03Sale20.021,00020,0210Jan 05 08:57 PM
Treace John T.Chief Executive OfficerDec 29Sale17.013,07552,3155,422,580Dec 30 06:01 PM
Treace John T.Chief Executive OfficerDec 28Sale16.9919,760335,8035,425,655Dec 30 06:01 PM
TREACE JAMES TDirectorDec 28Sale16.881,56326,3872Dec 30 06:00 PM
TREACE JAMES TDirectorDec 27Sale17.466,437112,3781,565Dec 27 08:09 PM
Treace John T.Chief Executive OfficerDec 27Sale17.4417,165299,3735,445,415Dec 27 08:10 PM
Treace John T.Chief Executive OfficerDec 23Sale16.9622,795386,5425,462,580Dec 27 08:10 PM
TREACE JAMES TDirectorDec 23Sale16.9012,610213,1598,002Dec 27 08:09 PM
TREACE JAMES TDirectorDec 22Sale16.2823,390380,70520,612Dec 27 08:09 PM
Treace John T.Chief Executive OfficerDec 22Sale16.2941,710679,3565,485,375Dec 27 08:10 PM
Treace John T.Chief Executive OfficerDec 21Sale16.1137,584605,5435,527,085Dec 22 07:05 PM
TREACE JAMES TDirectorDec 21Sale16.1414,881240,23844,002Dec 22 07:03 PM
TREACE JAMES TDirectorDec 20Sale15.7016,119253,1071,412,827Dec 22 07:03 PM
Treace John T.Chief Executive OfficerDec 20Sale15.7522,911360,8975,564,669Dec 22 07:05 PM
TREACE JAMES TDirectorDec 15Sale16.0675,0001,204,6431,055,258Dec 17 05:51 PM
TREACE JAMES TDirectorNov 24Sale17.8317,000303,0371,428,946Nov 24 08:49 PM
Treace John T.Chief Executive OfficerNov 24Sale17.8456,000999,2845,587,580Nov 24 08:48 PM
Treace John T.Chief Executive OfficerNov 23Sale17.4156,000974,6875,643,580Nov 24 08:48 PM
TREACE JAMES TDirectorNov 23Sale17.4817,000297,0881,445,946Nov 24 08:49 PM
TREACE JAMES TDirectorNov 22Sale18.5216,000296,2881,462,946Nov 24 08:49 PM
Treace John T.Chief Executive OfficerNov 22Sale18.3553,000972,5175,699,580Nov 24 08:48 PM
TREACE JAMES TDirectorNov 17Sale20.3325,000508,2502,130,258Nov 17 08:32 PM
TREACE JAMES TDirectorNov 16Sale20.8625,000521,5002,155,258Nov 17 08:32 PM
TREACE JAMES TDirectorNov 15Sale20.6325,000515,7652,180,258Nov 17 08:32 PM
Scanlan Sean F.SVP, MarketingNov 10Option Exercise1.5725,00039,25025,000Nov 12 07:00 PM
Scanlan Sean F.SVP, MarketingNov 10Sale21.5425,000538,4310Nov 12 07:00 PM
Treace John T.Chief Executive OfficerOct 22Sale20.7458,0891,204,9805,752,580Oct 22 09:36 PM
Treace John T.Chief Executive OfficerOct 21Sale20.7876,0841,581,1235,810,669Oct 22 09:36 PM
Treace John T.Chief Executive OfficerOct 20Sale24.9430,827768,9085,886,753Oct 22 09:36 PM
TIMBIE THOMAS EDirectorOct 20Sale25.1811,171281,2442,249,069Oct 22 09:35 PM
Ferguson Joe W.SVP, Research & DevelopmentOct 06Option Exercise0.10308,64130,864419,756Oct 08 04:04 PM
Owens Daniel E.Chief HR OfficerApr 27Buy17.004,00068,0004,000Apr 29 09:04 PM
Hair MarkChief Financial OfficerApr 27Buy17.003,60061,2003,600Apr 29 09:14 PM
Hair MarkChief Financial OfficerApr 27Buy17.0010,000170,00010,000Apr 29 09:14 PM
Frias Jaime A.See RemarksApr 27Sale17.00329,2305,596,91042,786Apr 29 09:09 PM
Treace John T.Chief Executive OfficerApr 27Sale17.005,253,80589,314,6855,917,580Apr 29 09:20 PM
TREACE JOHN RDirectorApr 27Sale17.00401,2506,821,2502,306,606Apr 29 09:13 PM